COP regimen: Difference between revisions
(Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} ==Overview== {{PAGENAME}} refers to a regimen consisting of xxx used to treat xxx. ==Regimen== {{chemo|x|xx}} {{chemo|x|xx}}...") |
No edit summary |
||
Line 18: | Line 18: | ||
==Indications== | ==Indications== | ||
* [[lymphoma|Malignant lymphoma]]<ref><ref name="pmid4935774">{{cite journal| author=Luce JK, Gamble JF, Wilson HE, Monto RW, Isaacs BL, Palmer RL et al.| title=Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma. | journal=Cancer | year= 1971 | volume= 28 | issue= 2 | pages= 306-17 | pmid=4935774 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4935774 }} </ref></ref> | |||
==References== | ==References== |
Revision as of 12:58, 12 March 2015
WikiDoc Resources for COP regimen |
Articles |
---|
Most recent articles on COP regimen Most cited articles on COP regimen |
Media |
Powerpoint slides on COP regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on COP regimen at Clinical Trials.gov Clinical Trials on COP regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on COP regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on COP regimen Discussion groups on COP regimen Patient Handouts on COP regimen Directions to Hospitals Treating COP regimen Risk calculators and risk factors for COP regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for COP regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:
Overview
COP regimen refers to a regimen consisting of xxx used to treat xxx.
Regimen
xxx
xxx
xxx
xxx
Indications
- Malignant lymphoma</ref>